Hamano et al. demonstrated that higher PSA nadir and shorter TTN are poor prognostic factors in men with mCRPC on ADT [24], and we might presume that TTN and PSA nadir are the effective predictors for disease progression in relative advanced prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.